dc.contributor.author | Zub, Kamila Anna | nb_NO |
dc.date.accessioned | 2014-12-19T14:19:05Z | |
dc.date.available | 2014-12-19T14:19:05Z | |
dc.date.created | 2014-07-03 | nb_NO |
dc.date.issued | 2014 | nb_NO |
dc.identifier | 732201 | nb_NO |
dc.identifier.isbn | 978-82-326-0216-2 (printed ver.) | nb_NO |
dc.identifier.isbn | 978-82-326-0217-9 (electronic ver.) | nb_NO |
dc.identifier.uri | http://hdl.handle.net/11250/263696 | |
dc.language | eng | nb_NO |
dc.publisher | Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisin | nb_NO |
dc.relation.ispartofseries | Doktoravhandlinger ved NTNU, 1503-8181; 2014:147 | nb_NO |
dc.title | Proteomic approaches to improve cancer therapy – Identifying factors contributing to melphalan resistance in multiple myeloma and to PDT mediated cytotoxicity | nb_NO |
dc.type | Doctoral thesis | nb_NO |
dc.contributor.department | Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisin | nb_NO |
dc.description.degree | PhD i molekylærmedisin | nb_NO |
dc.description.degree | PhD in Molecular Medicine | en_GB |